Cardlytics Inc (NASDAQ:CDLX) price on current trading day, rose 16.73% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.43.
A look at the stock’s price movement, the close in the last trading session was $1.23, moving within a range at $1.24 and $1.5654. The beta value (5-Year monthly) was 1.4. Turning to its 52-week performance, $15.89 and $1.22 were the 52-week high and 52-week low respectively. Overall, CDLX moved -29.21% over the past month.
Cardlytics Inc’s market cap currently stands at around $74.61 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-11.
Analysts have a consensus estimate of 58.07M for the company’s revenue for the quarter, with a low and high estimate of 57.6M and 58.8M respectively. The average forecast suggests down to a -14.10% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 272.78M, representing a -1.98% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CDLX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend CDLX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CDLX’s current price about -27.49% and -42.54% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.32, while 7-day volatility ratio is 20.87% and 13.39% in the 30-day chart. Further, Cardlytics Inc (CDLX) has a beta value of 1.41, and an average true range (ATR) of 0.25. Analysts have given the company’s stock an average 52-week price target of $3.5, forecast between a low of $3 and high of $4. Looking at the price targets, the low is -109.79% off current price level while to achieve the yearly target high, price needs to move -179.72%. Nonetheless, investors will most likely welcome a -144.76% jump to $3.5 which is the analysts’ median price.
If we refocus on Cardlytics Inc (NASDAQ:CDLX), historical trading data shows that trading volumes averaged 0.93 over the past 10 days and 1.07 million over the past 3 months. The company’s latest data on shares outstanding shows there are 51.26 million shares.
The 5.01% of Cardlytics Inc’s shares are in the hands of company insiders while institutional holders own 56.90% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.23 million on 2025-03-14, giving us a short ratio of 5.54. The data shows that as of 2025-03-14 short interest in Cardlytics Inc (CDLX) stood at 1880.9999999999998 of shares outstanding, with shares short falling to 8.33 million registered in 2025-02-14. Current price change has pushed the stock -61.46% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CDLX stock continues to rise going into the next quarter.
